TrialBreast cancer research : BCR2020

EFFECT: a randomized phase II study of efficacy and impact on function of two doses of nab-paclitaxel as first-line treatment in older women with advanced breast cancer.

Laura Biganzoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.